Refresh

Kwality Pharmaceuticals Ltd. - Research Center

539997 KPL Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

250.99 456.13 261.50 138.68 165.15
Expenses

Material consumed

110.07 201.07 166.54 87.48 119.59

Manufacturing expenses

12.96 11.06 6.11 4.19 3.70

Personnel expenses

29.90 20.09 15.68 11.69 8.43

Selling expenses

0.17 0.12 0.02 0.03 0.03

Adminstrative expenses

37.61 52.07 43.89 21.19 18.17

Expenses capitalised

- - - - -

Cost of sales

190.71 284.41 232.24 124.57 149.91

Operating profit

60.29 171.72 29.26 14.11 15.24

Other recurring income

2.94 3.51 1.59 3.92 0.93

Adjusted PBDIT

63.23 175.24 30.85 18.03 16.17

Financial expenses

6.02 2.92 2.61 2.50 2.21

Depreciation

14.92 10.64 6.44 4.39 3.06

Other write offs

- - - - -

Adjusted PBT

42.29 161.67 21.80 11.14 10.90

Tax charges

6.29 41.63 6.38 2.71 3.35

Adjusted PAT

36.00 120.05 15.42 8.43 7.55

Non recurring items

-16.86 - - - -

Other non cash adjustments

- - - - -

Reported net profit

19.14 120.05 15.42 8.43 7.55

Earnigs before appropriation

182.38 162.83 42.78 27.37 18.94

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

182.38 162.83 42.78 27.37 18.94
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com